NCT06373055View on ClinicalTrials.gov

Prediction of Therapeutic Response to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer Patients Using Spatial Transcriptomics

RecruitingOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

November 30, 2033

Study Completion Date

November 30, 2033

Conditions

Muscle-invasive Bladder Cancer

Interventions

OTHER

neoadjuvant chemotherapy followed by radical cystectomy

combination of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) or combination of gemcitabine and cisplatin (GC) followed by radical cystectomy

Trial Locations (1)

Unknown

RECRUITING

Department of Urology and Urological Science Institute, Yonsei University College of Medicine Seoul, Republic of Korea, Seoul

All Listed Sponsors

lead

Yonsei University

OTHER